CFO4Life Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,797
| Closed | -$251K | – | 241 |
|
2025
Q1 | $251K | Buy |
2,797
+167
| +6% | +$15K | 0.04% | 175 |
|
2024
Q4 | $262K | Sell |
2,630
-179
| -6% | -$17.8K | 0.05% | 170 |
|
2024
Q3 | $319K | Sell |
2,809
-75
| -3% | -$8.52K | 0.06% | 152 |
|
2024
Q2 | $357K | Buy |
2,884
+251
| +10% | +$31.1K | 0.07% | 136 |
|
2024
Q1 | $347K | Sell |
2,633
-157
| -6% | -$20.7K | 0.06% | 138 |
|
2023
Q4 | $304K | Buy |
2,790
+6
| +0.2% | +$654 | 0.06% | 140 |
|
2023
Q3 | $287K | Sell |
2,784
-5,673
| -67% | -$584K | 0.07% | 126 |
|
2023
Q2 | $976K | Buy |
8,457
+629
| +8% | +$72.6K | 0.21% | 55 |
|
2023
Q1 | $833K | Buy |
7,828
+692
| +10% | +$73.6K | 0.19% | 58 |
|
2022
Q4 | $792K | Buy |
+7,136
| New | +$792K | 0.17% | 71 |
|
2022
Q3 | – | Sell |
-2,297
| Closed | -$212K | – | 163 |
|
2022
Q2 | $212K | Sell |
2,297
-183
| -7% | -$16.9K | 0.05% | 133 |
|
2022
Q1 | $203K | Buy |
+2,480
| New | +$203K | 0.04% | 149 |
|